Health and Fitness Health and Fitness
Wed, February 4, 2009
[ Wed, Feb 04th 2009 ] - Market Wire
Inhibitex to Present at the 11th Annual BIO CEO & Investor Conference
[ Wed, Feb 04th 2009 ] - Market Wire
Community Health Systems to Broadcast Fourth-Quar .. ear-End 2008 Conference Call Live on the Internet
[ Wed, Feb 04th 2009 ] - Market Wire
Nanogen Establishes Scandinavian Gene Synthesis as New Licensee for Molecular In Vitro Diagnostics
[ Wed, Feb 04th 2009 ] - Market Wire
Clinical Data, Inc. To Present at BIO CEO & Investor Conference
[ Wed, Feb 04th 2009 ] - Market Wire
BioElectronics Corporation: BioElectronics Announ .. es Results of Menstrual Pain Pilot Clinical Study
[ Wed, Feb 04th 2009 ] - Market Wire
Oragenics, Inc. annonce un accord avec Garden of Life Inc. pour l'usage de ProBiora3
[ Wed, Feb 04th 2009 ] - Market Wire
COPAXONE® is Approved for Treatment of Patients .. t Clinical Event Suggestive of Multiple Sclerosis
[ Wed, Feb 04th 2009 ] - Market Wire
Urigen Pharmaceuticals: Urigen Announces Recent Insider Purchases Total Over 500,000 Shares
[ Wed, Feb 04th 2009 ] - Market Wire
Biofield Corp. Expands Arsenal Of Non-Invasive Diagnostic Devices
[ Wed, Feb 04th 2009 ] - Market Wire
Helicos Announces Improved Performance of Its Hel .. pe" Single Molecule Sequencer and tSMS" Chemistry
[ Wed, Feb 04th 2009 ] - Market Wire
Theravance, Inc.: GSK and Theravance announce pos .. nce-daily fluticasone furoate in the treatment of
[ Wed, Feb 04th 2009 ] - Market Wire
Conceptus® to Present at the ROTH 21st Annual OC Growth Stock Conference
[ Wed, Feb 04th 2009 ] - Market Wire
Bio-Imaging Technologies to Release Fourth Quarte .. Results and Host Conference Call on February 11,
[ Wed, Feb 04th 2009 ] - Market Wire
Oragenics, Inc., Announces Agreement with Garden of Life, Inc., for Use of ProBiora3
[ Wed, Feb 04th 2009 ] - Market Wire
UnitedHealth Group Makes It Simpler for Physician .. nister Health Care with Updated Customer ID Cards
[ Wed, Feb 04th 2009 ] - Market Wire
Progenics Appoints Peter J. Crowley as Independent Board Member
[ Wed, Feb 04th 2009 ] - Market Wire
Somaxon Pharmaceuticals to Present at the 11th Annual BIO CEO & Investor Conference
[ Wed, Feb 04th 2009 ] - Market Wire
EXACT Sciences Announces Issuance of Key Patent C .. ing Vimentin Gene for Colorectal Cancer Screening
[ Wed, Feb 04th 2009 ] - Market Wire
Applied Biosystems Delivers Integrated, Application-Focused Solutions on New SOLiD 3 System
[ Wed, Feb 04th 2009 ] - Market Wire
Sequenom to Hold Fourth Quarter and Full Year 200 .. Financial Results Conference Call on February 11
[ Wed, Feb 04th 2009 ] - Market Wire
Compugen Ltd. to Review Fourth Quarter and Year-E .. Financial Results on Wednesday, February 11, 2009
[ Wed, Feb 04th 2009 ] - Market Wire
MEDNAX, Inc. Acquires Neonatal Practice
[ Wed, Feb 04th 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. arter and Full Year 2008 Results and Conduct Conf
[ Wed, Feb 04th 2009 ] - Market Wire
Xenomics, Inc. Restructures and Extends Maturity of Convertible Debentures
Tue, February 3, 2009
[ Tue, Feb 03rd 2009 ] - Market Wire
AVANIR to Present at the 11th Annual BIO CEO & Investor Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
LifePoint Hospitals to Participate in 2009 UBS Global Healthcare Services Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
Edwards Lifesciences : Strong Heart Valve Sales Drive Edwards Lifesciences' Fourth Quarter Results
[ Tue, Feb 03rd 2009 ] - Market Wire
Allos Therapeutics Announces Final Results from P .. rexate in Patients with Peripheral T-cell Lymphom
[ Tue, Feb 03rd 2009 ] - Market Wire
Cytokinetics, Inc.: Cytokinetics to Announce Four .. Quarter and Year End Results on February 10, 2009
[ Tue, Feb 03rd 2009 ] - Market Wire
CardioNet, Inc. to Release Fourth Quarter and Full Year 2008 Earnings Results on February 17, 2009

CardioNet, Inc. to Release Fourth Quarter and Full Year 2008 Earnings Results on February 17, 2009


Published on 2009-02-03 15:14:11, Last Modified on 2009-02-03 15:14:35 - Market Wire
  Print publication without navigation


CONSHOHOCKEN, Penn.--([ BUSINESS WIRE ])--CardioNet, Inc. (NASDAQ:BEAT) will release its fourth quarter and full year 2008 earnings on Tuesday, February 17, 2009 at 4:00 PM, Eastern Time.

The CardioNet quarterly conference call will be held at 5:00 PM Eastern Time, Tuesday, February 17, 2009. The broadcast will be available through the investor information section of the CardioNet web page at [ www.cardionet.com ]. If you are unable to participate during the live webcast, an archive will be available on our website.

About CardioNet

CardioNet is the leading provider of ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health. CardioNet's initial efforts are focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders, with a solution that it markets as the CardioNet System. More information can be found at [ http://www.cardionet.com ].

Contributing Sources